Congratulations Mesoblast, ODAC voted yes for the Federal Drug and Administration approval of Remestemcel-L in Pedriatric Steroid-Refractory-Acute Graft-Versus-Host Disease/ Targeted Oncology-Immunotherapy, Biomarkers, and Cancer Pathways
Positive Announcement for Mesoblast (ODAC/FDA)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.04 |
Change
-0.050(4.61%) |
Mkt cap ! $1.184B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.12 | $1.02 | $19.77M | 18.88M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 76824 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 44736 | 13 |
View Market Depth
| Last trade - 13.29pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.05 |
Change
-0.050 ( 3.14 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.12 | $1.02 | 2125745 | ||
| Last updated 13.47pm 30/04/2024 ? | |||||
| MSB (ASX) Chart |